MedPath

Pred-Gati

Approved
Approval ID

65346afa-45cf-9f3b-e053-2991aa0ac8b1

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 22, 2018

Manufacturers
FDA

ImprimisRx NJ

DUNS: 931390178

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Prednisolone-Gatifloxacin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code70261-502
Product Classification
G
Generic Name
Prednisolone-Gatifloxacin
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateFebruary 22, 2018
FDA Product Classification

INGREDIENTS (3)

SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATEInactive
Quantity: 1.9 mg in 1 mL
Code: 70WT22SF4B
Classification: IACT
PREDNISOLONE ACETATEActive
Quantity: 10 mg in 1 mL
Code: 8B2807733D
Classification: ACTIB
GATIFLOXACIN HEMIHYDRATEActive
Quantity: 5 mg in 1 mL
Code: AN201CY09J
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Pred-Gati - FDA Drug Approval Details